Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute-phase reactants and coronary heart disease.

Wolfgang Koenig1, Robert S Rosenson

  • 1Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany. wolfgang.koenig@medzin.uni-ulm.de

Seminars in Vascular Medicine
|October 14, 2005
PubMed
Summary

Systemic inflammation is a key factor in atherosclerosis and cardiovascular events. Measuring inflammatory markers can improve coronary risk prediction and may be targeted by treatments like statins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.

American journal of preventive cardiology·2026
Same author

Capturing multi-disease states on a spectrum with machine learning and routine clinical data.

Med (New York, N.Y.)·2026
Same author

Remnant cholesterol - The transition from biomarker to risk factor.

Atherosclerosis·2026
Same author

Inclisiran in CKD: A Therapeutic Answer to a Persistent Treatment Gap.

Journal of the American Society of Nephrology : JASN·2026
Same author

Lipoprotein(a)-associated proteomic signature predicts cardiovascular disease in young adults.

The Journal of clinical investigation·2026
Same author

Associations of 10-year predicted ASCVD risk by the PREVENT equations with AI-analyzed coronary atherosclerotic plaque characteristics.

American journal of preventive cardiology·2026

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Inflammation is integral to atherosclerosis development, from initiation to plaque rupture.
  • Systemic inflammation markers predict cardiovascular events in diverse populations.
  • Inflammatory markers may enhance coronary risk assessment beyond traditional lipid profiles.

Purpose of the Study:

  • To review the role of inflammation in atherosclerosis.
  • To discuss the predictive value of inflammatory markers for cardiovascular events.
  • To explore the mechanisms and therapeutic implications of inflammation in cardiovascular disease.

Main Methods:

  • Literature review of prospective studies and clinical trials.
  • Analysis of biological mechanisms linking inflammation to vascular pathology.

Related Experiment Videos

  • Evaluation of evidence for anti-inflammatory therapies in cardiovascular prevention.

    • Main Results:

    • Prospective studies confirm inflammatory markers as predictors of cardiovascular events.
    • Inflammatory markers offer additive predictive value to cholesterol levels for coronary risk.
    • Clinical trials suggest benefits of aspirin, statins, and ACE inhibitors may involve modulating inflammatory responses.

    Conclusions:

    • Inflammation plays a critical role in the pathogenesis of atherosclerosis and cardiovascular events.
    • Inflammatory markers are valuable tools for cardiovascular risk stratification.
    • Targeting inflammatory pathways holds promise for cardiovascular disease prevention and treatment, though further research is needed.